LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases--a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial

被引：0

作者：

Carl Christoph Schimanski

Markus Möhler

Michael Schön

Eric van Cutsem

Richard Greil

Wolf Otto Bechstein

Susanna Hegewisch-Becker

Götz von Wichert

Matthias Vöhringer

Michael Heike

Volker Heinemann

Marc Peeters

Stephan Kanzler

Stefan Kasper

Friedrich Overkamp

Jan Schröder

Daniel Seehofer

Frank Kullmann

Bernhard Linz

Irene Schmidtmann

Victoria Smith-Machnow

Ines Gockel

Hauke Lang

Peter R Galle

机构：

[1] University Medical Center (UMC),First Deptartment of Internal Medicine

[2] University Hospital of Mainz,Department of General and Abdominal Surgery

[3] Municipal Hospital of Karlsruhe,Digestive Oncology Unit

[4] University Hospital Gasthuisberg,Third Department of Internal Medicine

[5] University Medical Center (UMC),Department of General and Abdominal Surgery

[6] University Hospital of Salzburg,First Department of Internal Medicine

[7] University Medical Center (UMC),Center of Internal Medicine

[8] University Hospital of Frankfurt,Med. Klinik Mitte

[9] Onkologische Schwerpunktpraxis Eppendorf,Third Department of Internal Medicine

[10] University Medical Center (UMC),Department of Oncology

[11] University Hospital of Ulm,Department of Internal Medicine

[12] Robert-Bosch Hospital,Department of Internal Medicine

[13] Hospital of Dortmund,Outpatient center for hematology and oncology

[14] University Hospital of Großhadern,Department of General, Visceral and Transplantation Surgery

[15] Antwerp University Hospital,First Department of Internal Medicine

[16] Leopoldina Hospital,Institute of Medical Biometrics, Epidemiology and Informatics (IMBEI)

[17] University Medical Center (UMC),Department of General and Abdominal Surgery

[18] University Hospital of Essen,First Dept. of Internal Medicine

[19] Oncologianova GmbH,undefined

[20] Mühlheim an der Ruhr,undefined

[21] Campus Virchow Klinikum,undefined

[22] Humboldt University,undefined

[23] Kliniken Nordoberpfalz AG,undefined

[24] Outpatient center for hematology and oncology,undefined

[25] University Medical Center (UMC),undefined

[26] University Hospital of Mainz,undefined

[27] iOMEDICO,undefined

[28] University Medical Center (UMC),undefined

[29] University Hospital of Mainz,undefined

[30] University Medical Center (UMC),undefined

[31] University Hospital of Mainz,undefined

来源：

BMC Cancer | / 12卷

关键词：

Liver Metastasis; Hepatic Metastasis; DPPC; ECOG Performance Status; MUC1 Expression;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases-a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial
Schimanski, Carl Christoph
Moehler, Markus
Schoen, Michael
van Cutsem, Eric
Greil, Richard
Bechstein, Wolf Otto
Hegewisch-Becker, Susanna
von Wichert, Goetz
Voehringer, Matthias
Heike, Michael
Heinemann, Volker
Peeters, Marc
Kanzler, Stephan
Kasper, Stefan
Overkamp, Friedrich
Schroeder, Jan
Seehofer, Daniel
Kullmann, Frank
Linz, Bernhard
Schmidtmann, Irene
Smith-Machnow, Victoria
Gockel, Ines
Lang, Hauke
Galle, Peter R.
BMC CANCER, 2012, 12
[2] LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases-A randomized, double-blind, placebo-controlled, multicenter, multinational, phase II trial.
Schimanski, C. C.
Galle, P. R.
Lang, H.
Schoen, M.
Moehler, M. H.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[3] A randomized, double-blinded, placebo-controlled multicenter phase II trial of adjuvant immunotherapy with tecemotide (L-BLP25) after R0/R1 hepatic colorectal cancer metastasectomy (LICC): Final results.
Schimanski, Carl Christoph
Kasper, Stefan
Hegewisch-Becker, Susanna
Schroeder, Jan
Overkamp, Friedrich
Kullmann, Frank
Bechstein, Wolf Otto
Vohringer, Matthias
Oellinger, Robert
Lordick, Florian
Heinemann, Volker
Geissler, Michael
Schulz-Abelius, Armin
Linz, Bernhard
Bernhard, Helga
Schoen, Michael R.
Greil, Richard
Smith-Machnow, Victoria
Schmidtmann, Irene
Moehler, Markus Hermann
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
[4] A randomized, double-blinded, placebo-controlled multicenter phase II trial of adjuvant immunotherapy with tecemotide (L-BLP25) after R0/R1 hepatic colorectal cancer metastasectomy (LICC): Final results.
Schimanski, Carl Christoph
Kasper, Stefan
Hegewisch-Becker, Susanna
Schroeder, Jan
Overkamp, Friedrich
Kullmann, Frank
Bechstein, Wolf Otto
Voehringer, Matthias
Oellinger, Robert
Lordick, Florian
Heinemann, Volker
Geissler, Michael
Schulz-Abelius, Armin
Linz, Bernhard
Bernhard, Helga
Schoen, Michael R.
Greil, Richard
Smith-Machnow, Victoria
Schmidtmann, Irene
Moehler, Markus Hermann
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[5] A randomized, double-blind, placebo-controlled, multicenter, multinational, phase II trial of immunotherapy with L-BLP25 in patients with colorectal carcinoma following R0/R1 hepatic metastasectomy
Schimanski, C. C.
Moehler, M.
Lang, H.
Smith-Machnow, V
Kanzler, S.
Hegewisch-Becker, S.
Doerfel, S.
Seehofer, D.
Bechstein, W. O.
Heike, M.
Overkamp, F.
Kullmann, F.
Voehringer, M.
Heinemann, V
von Wichert, G.
Kasper, S.
Greil, R.
Schroeder, J.
Galle, P. R.
Schoen, M.
ONKOLOGIE, 2012, 35 : 57 - 57
[6] A randomized, double-blind, placebo-controlled, multicenter, multinational, phase II trial immunotherapy with L-BLP25 (tecemotide) in patients with colorectal carcinoma following R0/R1 hepatic metastasectomy
Kasper, Stefan
Overkamp, Friedrich
Moehler, Markus Hermann
Kullmann, Frank
Lang, Hauke
Schoen, Michael
Smith-Machnow, Victoria
Hegewisch-Becker, Susanna
Seehofer, Daniel
Bechstein, Wolf
Heike, Michael
Voehringer, Matthias
Heinemann, Volker
Greil, Richard
Geissler, Michael
Lordick, Florian
Peeters, Marc
Van Cutsem, Eric
Galle, Peter Robert
Schimanski, Carl Christoph
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[7] Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC)
Schimanski, Carl Christoph
Kasper, Stefan
Hegewisch-Becker, Susanna
Schroeder, Jan
Overkamp, Friedrich
Kullmann, Frank
Bechstein, Wolf Otto
Voehringer, Matthias
Oellinger, Robert
Lordick, Florian
Heinemann, Volker
Geissler, Michael
Schulz-Abelius, Armin
Bernhard, Helga
Schoen, Michael R.
Greil, Richard
Galle, Peter
Lang, Hauke
Schmidtmann, Irene
Moehler, Markus
ONCOIMMUNOLOGY, 2020, 9 (01):
[8] A randomized, double-blind, placebo-controlled, multicenter, binational, phase II trial of immunotherapy with L-BLP25 (tecemotide) in patients with colorectal carcinoma following R0/R1 hepatic metastasectomy.
Kasper, Stefan
Moehler, Markus
Hegewisch-Becker, Susanna
Overkamp, Friedrich
Bechstein, Wolf O.
Kullmann, Frank
Lang, Hauke
Schoen, Michael
Smith-Machnow, Victoria
Seehofer, Daniel
Voehringer, Matthias
Geissler, Michael
Greil, Richard
Heike, Michael
Heinemann, Volker
Lordick, Florian
Galle, Peter R.
Schimanski, Carl Christoph
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[9] Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial
Xu, Rui-Hua
Shen, Lin
Wang, Ke-Ming
Wu, Gang
Shi, Chun-Mei
Ding, Ke-Feng
Lin, Li-Zhu
Wang, Jin-Wan
Xiong, Jian-Ping
Wu, Chang-Ping
Li, Jin
Liu, Yun-Peng
Wang, Dong
Ba, Yi
Feng, Jue-Ping
Bai, Yu-Xian
Bi, Jing-Wang
Ma, Li-Wen
Lei, Jian
Yang, Qing
Yu, Hao
CHINESE JOURNAL OF CANCER, 2017, 36
[10] Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer:a multicenter, randomized,double-blinded,placebo-controlled,phase Ⅱclinical trial
RuiHua Xu
Lin Shen
KeMing Wang
Gang Wu
ChunMei Shi
KeFeng Ding
LiZhu Lin
JinWan Wang
JianPing Xiong
ChangPing Wu
Jin Li
YunPeng Liu
Dong Wang
Yi Ba
JuePing Feng
YuXian Bai
JingWang Bi
LiWen Ma
Jian Lei
Qing Yang
Hao Yu
Chinese Journal of Cancer, 2017, 36 (12) : 677 - 685

← 1 2 3 4 5 →